{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T14:40:12Z","timestamp":1783694412647,"version":"3.55.0"},"reference-count":113,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:00:00Z","timestamp":1752624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Allergy"],"abstract":"<jats:p>Galectin-9 (Gal-9) is a multifunctional immunomodulatory molecule involved in cell growth, differentiation, adhesion, communication, and death. Galectin-9 mediates its physiological functions through interactions with multiple membrane receptors, including T-cell immunoglobulin mucin-domain containing-3 (Tim-3), immunoglobulin E, and the hyaluronan receptor CD44. In recent years, Gal-9 has been extensively studied in autoimmune diseases, tumor microenvironments, and viral infections. The circulating levels of this lectin demonstrate clinical correlation with disease progression in both acute and chronic infectious conditions. In addition, Gal-9 can potentially be a reliable, sensitive, and noninvasive biomarker of disease severity in many skin diseases. However, there has not been a review of Gal-9 studies in patients with dermatosis. This review summarizes recent advances in understanding Gal-9's immunomodulatory mechanisms in chronic spontaneous urticaria pathophysiology, systemic lupus erythematosus, atopic dermatitis, melanoma, systemic sclerosis, herpes simplex virus infection, bullous pemphigoid, psoriasis, vitiligo, maculopapular exanthema, and skin grafting to provide a reference for future research. Gal-9 is an important regulator of immune homeostasis whose level changes significantly in many skin diseases, and validation was performed in a mouse model using exogenous Gal-9. Ongoing studies are necessary to clarify the pathophysiology of Gal-9, identify the potential of Gal-9 as a new biomarker, and develop new therapeutic approaches for skin diseases.<\/jats:p>","DOI":"10.3389\/falgy.2025.1614277","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T05:39:04Z","timestamp":1752644344000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Galectin-9: diverse roles in skin disease"],"prefix":"10.3389","volume":"6","author":[{"given":"Lin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuqiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.1749-6632.2009.05131.x","article-title":"Galectins: regulators of acute and chronic inflammation","volume":"1183","author":"Liu","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"B2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12565-016-0366-6","article-title":"Tissue- and cell-specific localization of galectins, beta-galactose-binding animal lectins, and their potential functions in health and disease","volume":"92","author":"Nio-Kobayashi","year":"2017","journal-title":"Anat Sci Int"},{"key":"B3","doi-asserted-by":"publisher","first-page":"104287","DOI":"10.1016\/j.cellimm.2021.104287","article-title":"Galectin-9 as a biomarker of disease severity","volume":"361","author":"Moar","year":"2021","journal-title":"Cell Immunol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000053623","article-title":"Ecalectin\/galectin-9, a novel eosinophil chemoattractant: its function and production","volume":"122","author":"Hirashima","year":"2000","journal-title":"Int Arch Allergy Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1023\/B:GLYC.0000014090.63206.2f","article-title":"Galectin-9 in physiological and pathological conditions","volume":"19","author":"Hirashima","year":"2002","journal-title":"Glycoconj J"},{"key":"B6","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1189\/jlb.5A1214-582R","article-title":"HCV-infected cells and differentiation increase monocyte immunoregulatory galectin-9 production","volume":"99","author":"Harwood","year":"2016","journal-title":"J Leukoc Biol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e72488","DOI":"10.1371\/journal.pone.0072488","article-title":"Cis association of galectin-9 with Tim-3 differentially regulates IL-12\/IL-23 expressions in monocytes via TLR signaling","volume":"8","author":"Ma","year":"2013","journal-title":"PLoS One"},{"key":"B8","doi-asserted-by":"publisher","first-page":"10650","DOI":"10.1073\/pnas.1017954108","article-title":"Galectin-9 binding to cell surface protein disulfide isomerase regulates the redox environment to enhance T-cell migration and HIV entry","volume":"108","author":"Bi","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B9","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.clim.2008.01.006","article-title":"Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis","volume":"127","author":"Seki","year":"2008","journal-title":"Clin Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/nature13848","article-title":"CEACAM1 Regulates TIM-3-mediated tolerance and exhaustion","volume":"517","author":"Huang","year":"2015","journal-title":"Nature"},{"key":"B11","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/s41467-021-21099-2","article-title":"Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy","volume":"12","author":"Yang","year":"2021","journal-title":"Nat Commun"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1126\/science.1148536","article-title":"Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells","volume":"318","author":"Anderson","year":"2007","journal-title":"Science"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2974","DOI":"10.4049\/jimmunol.175.5.2974","article-title":"Galectin-9 induces maturation of human monocyte-derived dendritic cells","volume":"175","author":"Dai","year":"2005","journal-title":"J Immunol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1164\/rccm.200608-1243OC","article-title":"Galectin-9 inhibits CD44-hyaluronan interaction and suppresses a murine model of allergic asthma","volume":"176","author":"Katoh","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2721","DOI":"10.4049\/jimmunol.1700575","article-title":"Regulatory T cell-mediated suppression of inflammation induced by DR3 signaling is dependent on galectin-9","volume":"199","author":"Madireddi","year":"2017","journal-title":"J Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"e38708","DOI":"10.1371\/journal.pone.0038708","article-title":"Galectin-9 controls CD40 signaling through a Tim-3 independent mechanism and redirects the cytokine profile of pathogenic T cells in autoimmunity","volume":"7","author":"Vaitaitis","year":"2012","journal-title":"PLoS One"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1084\/jem.20132687","article-title":"Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodies","volume":"211","author":"Madireddi","year":"2014","journal-title":"J Exp Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"580557","DOI":"10.3389\/fimmu.2020.580557","article-title":"Ligand-Receptor interactions of galectin-9 and VISTA suppress human T lymphocyte cytotoxic activity","volume":"11","author":"Yasinska","year":"2020","journal-title":"Front Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/nm.4314","article-title":"Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance","volume":"23","author":"Daley","year":"2017","journal-title":"Nat Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/path.5093","article-title":"CD206-positive myeloid cells bind galectin-9 and promote a tumor-supportive microenvironment","volume":"245","author":"Enninga","year":"2018","journal-title":"J Pathol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"6078","DOI":"10.1074\/jbc.272.9.6078","article-title":"Identification and characterization of galectin-9, a novel beta-galactoside-binding mammalian lectin","volume":"272","author":"Wada","year":"1997","journal-title":"J Biol Chem"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1038\/ni1271","article-title":"The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity","volume":"6","author":"Zhu","year":"2005","journal-title":"Nat Immunol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.clim.2012.01.004","article-title":"Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner","volume":"143","author":"Oomizu","year":"2012","journal-title":"Clin Immunol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"32344","DOI":"10.1074\/jbc.M109.035196","article-title":"Galectin-9 is a high affinity IgE-binding lectin with anti-allergic effect by blocking IgE-antigen complex formation","volume":"284","author":"Niki","year":"2009","journal-title":"J Biol Chem"},{"key":"B25","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.clim.2009.09.004","article-title":"Galectin-9 ameliorates immune complex-induced arthritis by regulating Fc gamma R expression on macrophages","volume":"133","author":"Arikawa","year":"2009","journal-title":"Clin Immunol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1111\/all.13847","article-title":"Expression of the Tim3-galectin-9 axis is altered in drug-induced maculopapular exanthema","volume":"74","author":"Fernandez-Santamar\u00eda","year":"2019","journal-title":"Allergy"},{"key":"B27","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.immuni.2014.06.011","article-title":"Galectin-9-CD44 interaction enhances stability and function of adaptive regulatory T cells","volume":"41","author":"Wu","year":"2014","journal-title":"Immunity"},{"key":"B28","doi-asserted-by":"publisher","first-page":"E102","DOI":"10.1002\/med.20249","article-title":"Therapeutic potential of galectin-9 in human disease","volume":"33","author":"Wiersma","year":"2013","journal-title":"Med Res Rev"},{"key":"B29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/JVI.02214-20","article-title":"Effect of the use of galectin-9 and blockade of TIM-3 receptor in the latent cellular reservoir of HIV-1","volume":"95","author":"Sanz","year":"2021","journal-title":"J Virol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1093\/glycob\/cwq214","article-title":"Galectin-9 regulates T helper cell function independently of Tim-3","volume":"21","author":"Su","year":"2011","journal-title":"Glycobiology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.3390\/ijms18102108","article-title":"Translational implication of galectin-9 in the pathogenesis and treatment of viral infection","volume":"18","author":"Lai","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B32","doi-asserted-by":"publisher","first-page":"e86106","DOI":"10.1371\/journal.pone.0086106","article-title":"Galectin-9 enhances cytokine secretion, but suppresses survival and degranulation, in human mast cell line","volume":"9","author":"Kojima","year":"2014","journal-title":"PLoS One"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/cimm.1994.1148","article-title":"Activation of rat basophilic leukemia cells by epsilon BP, an IgE-binding endogenous lectin","volume":"156","author":"Zuberi","year":"1994","journal-title":"Cell Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"102575","DOI":"10.1016\/j.jaut.2020.102575","article-title":"Galectin-9 bridges human B cells to vascular endothelium while programming regulatory pathways","volume":"117","author":"Chakraborty","year":"2021","journal-title":"J Autoimmun"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1111\/j.1398-9995.2006.01130.x","article-title":"Regulatory mechanisms of galectin-9 and eotaxin-3 synthesis in epidermal keratinocytes: possible involvement of galectin-9 in dermal eosinophilia of Th1-polarized skin inflammation","volume":"61","author":"Igawa","year":"2006","journal-title":"Allergy"},{"key":"B36","doi-asserted-by":"publisher","first-page":"7660","DOI":"10.4049\/jimmunol.181.11.7660","article-title":"Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions","volume":"181","author":"Nagahara","year":"2008","journal-title":"J Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"108155","DOI":"10.1016\/j.intimp.2021.108155","article-title":"Functional role of galectin-9 in directing human innate immune reactions to Gram-negative bacteria and T cell apoptosis","volume":"100","author":"Schlichtner","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1007\/s11596-020-2238-5","article-title":"Down-regulation and clinical implication of galectin-9 levels in patients with acute coronary syndrome and chronic kidney disease","volume":"40","author":"Xie","year":"2020","journal-title":"Curr Med Sci"},{"key":"B39","doi-asserted-by":"publisher","first-page":"604265","DOI":"10.3389\/fimmu.2020.604265","article-title":"Galectin-9: a suppressor of atherosclerosis?","volume":"11","author":"Yu","year":"2020","journal-title":"Front Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/leu.2010.25","article-title":"Galectin-9 exhibits anti-myeloma activity through JNK and p38 MAP kinase pathways","volume":"24","author":"Kobayashi","year":"2010","journal-title":"Leukemia"},{"key":"B41","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/ni.2376","article-title":"Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1","volume":"13","author":"Chiba","year":"2012","journal-title":"Nat Immunol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1002\/ijc.10436","article-title":"Possible role of galectin-9 in cell aggregation and apoptosis of human melanoma cell lines and its clinical significance","volume":"99","author":"Kageshita","year":"2002","journal-title":"Int J Cancer"},{"key":"B43","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.7314\/APJCP.2012.13.6.2503","article-title":"Galectin-9 acts as a prognostic factor with antimetastatic potential in hepatocellular carcinoma","volume":"13","author":"Zhang","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"key":"B44","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1002\/art.40399","article-title":"Increased expression and modulated regulatory activity of coinhibitory receptors PD-1, TIGIT, and TIM-3 in lymphocytes from patients with systemic sclerosis.","volume":"70","author":"Fleury","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/j.clinbiochem.2012.04.009","article-title":"Galectins testing: new promises for the diagnosis and risk stratification of chronic diseases?","volume":"45","author":"Gruson","year":"2012","journal-title":"Clin Biochem"},{"key":"B46","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1111\/all.13397","article-title":"The EAACI\/GA(2)LEN\/EDF\/WAO guideline for the definition, classification, diagnosis and management of urticaria","volume":"73","author":"Zuberbier","year":"2018","journal-title":"Allergy"},{"key":"B47","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/all.15603","article-title":"Chronic spontaneous urticaria: focus on pathophysiology to unlock treatment advances","volume":"78","author":"Kaplan","year":"2023","journal-title":"Allergy"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1016\/j.jaci.2022.04.010","article-title":"Autoimmune chronic spontaneous urticaria","volume":"149","author":"Kolkhir","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1111\/all.16239","article-title":"In chronic spontaneous urticaria, increased galectin-9 expression on basophils and eosinophils is linked to high disease activity, endotype-specific markers, and response to omalizumab treatment","volume":"79","author":"Ji","year":"2024","journal-title":"Allergy"},{"key":"B50","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1111\/all.13835","article-title":"Serum galectin-1, galectin-3, and galectin-9 are bystander molecules for chronic spontaneous urticaria","volume":"74","author":"Zheng","year":"2019","journal-title":"Allergy"},{"key":"B51","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.coi.2016.09.001","article-title":"T cells in systemic lupus erythematosus","volume":"43","author":"Suarez-Fueyo","year":"2016","journal-title":"Curr Opin Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"102736","DOI":"10.1016\/j.autrev.2020.102736","article-title":"B cell activating factor (BAFF): structure, functions, autoimmunity and clinical implications in systemic lupus erythematosus (SLE)","volume":"20","author":"M\u00f6ckel","year":"2021","journal-title":"Autoimmun Rev"},{"key":"B53","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1177\/09612033221082907","article-title":"Serum and urinary galectin-9 and C-X-C motif chemokine ligand 10","volume":"31","author":"Mehta","year":"2022","journal-title":"Lupus"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1136\/annrheumdis-2018-213497","article-title":"Galectin-9 is an easy to measure biomarker for the interferon signature in systemic lupus erythematosus and antiphospholipid syndrome","volume":"77","author":"van den Hoogen","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"B55","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00403-016-1665-4","article-title":"Expression of human T cell immunoglobulin domain and mucin-3 (TIM-3) and TIM-3 ligands in peripheral blood from patients with systemic lupus erythematosus","volume":"308","author":"Jiao","year":"2016","journal-title":"Arch Dermatol Res"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e0227069","DOI":"10.1371\/journal.pone.0227069","article-title":"Galectin-9 as a biomarker for disease activity in systemic lupus erythematosus","volume":"15","author":"Matsuoka","year":"2020","journal-title":"PLoS One"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1172\/JCI97333","article-title":"Galectin-9 inhibits TLR7-mediated autoimmunity in murine lupus models","volume":"128","author":"Panda","year":"2018","journal-title":"J Clin Invest"},{"key":"B58","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1177\/09612033211002275","article-title":"Plasma checkpoint protein levels and galectin-9 in juvenile systemic lupus erythematosus","volume":"30","author":"Yuksel","year":"2021","journal-title":"Lupus"},{"key":"B59","doi-asserted-by":"publisher","first-page":"5806","DOI":"10.4049\/jimmunol.0903435","article-title":"TIM-3: a novel regulatory molecule of alloimmune activation","volume":"185","author":"Boenisch","year":"2010","journal-title":"J Immunol"},{"key":"B60","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s11033-009-9833-7","article-title":"TIM-3 as a new therapeutic target in systemic lupus erythematosus","volume":"37","author":"Pan","year":"2010","journal-title":"Mol Biol Rep"},{"key":"B61","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1177\/1759720X13485503","article-title":"Biomarkers in systemic lupus erythematosus: challenges and prospects for the future","volume":"5","author":"Liu","year":"2013","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1038\/s41590-018-0256-2","article-title":"The epithelial immune microenvironment (EIME) in atopic dermatitis and psoriasis","volume":"19","author":"Dainichi","year":"2018","journal-title":"Nat Immunol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1111\/1346-8138.12884","article-title":"Elevated serum galectin-9 levels in patients with atopic dermatitis","volume":"42","author":"Nakajima","year":"2015","journal-title":"J Dermatol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"952338","DOI":"10.3389\/fimmu.2022.952338","article-title":"Galectin-9 contributes to the pathogenesis of atopic dermatitis via T cell immunoglobulin mucin-3","volume":"13","author":"Su","year":"2022","journal-title":"Front Immunol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"947","DOI":"10.3390\/cells10040947","article-title":"The role of galectin-9 as mediator of atopic dermatitis: effect on keratinocytes","volume":"10","author":"Corr\u00eaa","year":"2021","journal-title":"Cells"},{"key":"B66","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4103\/ijdvl.IJDVL_252_18","article-title":"Serum galectin-9 levels in atopic dermatitis, psoriasis and allergic contact dermatitis: a cross-sectional study","volume":"85","author":"Nofal","year":"2019","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.3389\/fimmu.2019.03063","article-title":"Galectin-9 induced by dietary probiotic mixture regulates immune balance to reduce atopic dermatitis symptoms in mice","volume":"10","author":"Kim","year":"2019","journal-title":"Front Immunol"},{"key":"B68","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.clim.2009.04.012","article-title":"Stable form of galectin-9, a Tim-3 ligand, inhibits contact hypersensitivity and psoriatic reactions: a potent therapeutic tool for Th1- and\/or Th17-mediated skin inflammation","volume":"132","author":"Niwa","year":"2009","journal-title":"Clin Immunol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1615\/CritRevEukaryotGeneExpr.2020028454","article-title":"Malignant melanoma: skin cancer-diagnosis, prevention, and treatment","volume":"30","author":"Ahmed","year":"2020","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"B70","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1158\/2326-6066.CIR-16-0288","article-title":"Long-term survival and clinical benefit from adoptive T-cell transfer in stage IV melanoma patients is determined by a four-parameter tumor immune signature","volume":"5","author":"Melief","year":"2017","journal-title":"Cancer Immunol Res"},{"key":"B71","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.clim.2008.09.014","article-title":"Galectin-9 expands unique macrophages exhibiting plasmacytoid dendritic cell-like phenotypes that activate NK cells in tumor-bearing mice","volume":"130","author":"Nobumoto","year":"2009","journal-title":"Clin Immunol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1131379","DOI":"10.3389\/fimmu.2023.1131379","article-title":"Galectin-9 promotes natural killer cells activity via interaction with CD44","volume":"14","author":"Rahmati","year":"2023","journal-title":"Front Immunol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1038\/jid.2012.133","article-title":"The glycan-binding protein galectin-9 has direct apoptotic activity toward melanoma cells","volume":"132","author":"Wiersma","year":"2012","journal-title":"J Invest Dermatol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s42003-024-05891-6","article-title":"Tumor-targeted nanodrug FSGG\/siGal-9 for transdermal photothermal immunotherapy of melanoma","volume":"7","author":"Ren","year":"2024","journal-title":"Commun Biol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1093\/glycob\/cwn062","article-title":"Galectin-9 suppresses tumor metastasis by blocking adhesion to endothelium and extracellular matrices","volume":"18","author":"Nobumoto","year":"2008","journal-title":"Glycobiology"},{"key":"B76","doi-asserted-by":"publisher","first-page":"10376","DOI":"10.1111\/jcmm.16967","article-title":"Cancer testis antigen PRAME: an anti-cancer target with immunomodulatory potential","volume":"25","author":"Naik","year":"2021","journal-title":"J Cell Mol Med"},{"key":"B77","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"B78","doi-asserted-by":"publisher","first-page":"102211","DOI":"10.1016\/j.coph.2022.102211","article-title":"Current advances in the treatment of systemic sclerosis","volume":"64","author":"Bukiri","year":"2022","journal-title":"Curr Opin Pharmacol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jaut.2019.04.008","article-title":"The identification of CCL18 as biomarker of disease activity in localized scleroderma","volume":"101","author":"Mertens","year":"2019","journal-title":"J Autoimmun"},{"key":"B80","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13075-015-0669-3","article-title":"Gene expression changes reflect clinical response in a placebo-controlled randomized trial of Abatacept in patients with diffuse cutaneous systemic sclerosis","volume":"17","author":"Chakravarty","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1016\/j.jid.2017.04.035","article-title":"Systemic sclerosis dermal fibroblasts suppress Th1 cytokine production via galectin-9 overproduction due to Fli1 deficiency","volume":"137","author":"Saigusa","year":"2017","journal-title":"J Invest Dermatol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"9473243","DOI":"10.1155\/2018\/9473243","article-title":"Clinical significance of serum galectin-9 and soluble CD155 levels in patients with systemic sclerosis","volume":"2018","author":"Chihara","year":"2018","journal-title":"J Immunol Res"},{"key":"B83","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1002\/art.1780200410","article-title":"Cellular infiltrates in scleroderma skin","volume":"20","author":"Fleischmajer","year":"1977","journal-title":"Arthritis Rheum"},{"key":"B84","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/1346-8138.13610","article-title":"Clinical significance of serum soluble T-cell immunoglobulin and mucin domain 3 levels in systemic sclerosis: association with disease severity","volume":"44","author":"Chiba","year":"2017","journal-title":"J Dermatol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/S0140-6736(00)04638-9","article-title":"Herpes simplex virus infections","volume":"357","author":"Whitley","year":"2001","journal-title":"Lancet"},{"key":"B86","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1056\/NEJM198902023200506","article-title":"Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome","volume":"320","author":"Erlich","year":"1989","journal-title":"N Engl J Med"},{"key":"B87","doi-asserted-by":"publisher","first-page":"10606","DOI":"10.1128\/JVI.01391-12","article-title":"TNFRSF25 agonistic antibody and galectin-9 combination therapy controls herpes simplex virus-induced immunoinflammatory lesions","volume":"86","author":"Reddy","year":"2012","journal-title":"J Virol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"e1000882","DOI":"10.1371\/journal.ppat.1000882","article-title":"Galectin-9\/TIM-3 interaction regulates virus-specific primary and memory CD8T cell response","volume":"6","author":"Sehrawat","year":"2010","journal-title":"PLoS Pathog"},{"key":"B89","doi-asserted-by":"publisher","first-page":"5745","DOI":"10.4049\/jimmunol.1102105","article-title":"Influence of galectin-9\/Tim-3 interaction on herpes simplex virus-1 latency","volume":"187","author":"Reddy","year":"2011","journal-title":"J Immunol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1177\/205873929901200202","article-title":"A Th2-like cytokine response is involved in bullous pemphigoid. The role of IL-4 and IL-5 in the pathogenesis of the disease","volume":"12","author":"Feliciani","year":"1999","journal-title":"Int J Immunopathol Pharmacol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.clim.2006.03.014","article-title":"Increased expression of Th2-associated chemokines in bullous pemphigoid disease. Role of eosinophils in the production and release of these chemokines","volume":"120","author":"Gounni Abdelilah","year":"2006","journal-title":"Clin Immunol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jaut.2018.09.003","article-title":"IL-17A is functionally relevant and a potential therapeutic target in bullous pemphigoid","volume":"96","author":"Chakievska","year":"2019","journal-title":"J Autoimmun"},{"key":"B93","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1111\/jdv.16780","article-title":"Expression of PD-1 and Tim-3 is increased in skin of patients with bullous pemphigoid and pemphigus vulgaris","volume":"35","author":"Ernst","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"4833","DOI":"10.1038\/s41598-017-04687-5","article-title":"Eosinophil cationic protein (ECP), a predictive marker of bullous pemphigoid severity and outcome","volume":"7","author":"Giusti","year":"2017","journal-title":"Sci Rep"},{"key":"B95","doi-asserted-by":"publisher","first-page":"201","DOI":"10.3389\/fmed.2018.00201","article-title":"The role of eosinophils in bullous pemphigoid: a developing model of eosinophil pathogenicity in mucocutaneous disease","volume":"5","author":"Amber","year":"2018","journal-title":"Front Med (Lausanne"},{"key":"B96","doi-asserted-by":"publisher","first-page":"adv00419","DOI":"10.2340\/00015555-3771","article-title":"Immunomodulator galectin-9 is increased in blood and skin of patients with bullous pemphigoid","volume":"101","author":"Pruessmann","year":"2021","journal-title":"Acta Derm Venereol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1590\/abd1806-4841.20199007","article-title":"Bullous pemphigoid","volume":"94","author":"Miyamoto","year":"2019","journal-title":"An Bras Dermatol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"B99","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/bjd.20090","article-title":"Signalling of multiple interleukin (IL)-17 family cytokines via IL-17 receptor A drives psoriasis-related inflammatory pathways","volume":"185","author":"Tollenaere","year":"2021","journal-title":"Br J Dermatol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.jid.2021.06.026","article-title":"Differential involvement of programmed cell death ligands in skin immune responses","volume":"142","author":"Tanaka","year":"2022","journal-title":"J Invest Dermatol"},{"key":"B101","doi-asserted-by":"publisher","first-page":"110741","DOI":"10.1016\/j.humimm.2023.110741","article-title":"The elevation of plasma galectin-9 levels in patients with psoriasis and its associations with inflammatory and immune checkpoint molecules in skin tissues","volume":"85","author":"Chagan-Yasutan","year":"2024","journal-title":"Hum Immunol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"13313","DOI":"10.3390\/ijms241713313","article-title":"Challenges and future trends in the treatment of psoriasis","volume":"24","author":"Lee","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B103","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S0140-6736(14)60763-7","article-title":"Vitiligo","volume":"386","author":"Ezzedine","year":"2015","journal-title":"Lancet"},{"key":"B104","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1146\/annurev-immunol-100919-023531","article-title":"Vitiligo: mechanisms of pathogenesis and treatment","volume":"38","author":"Frisoli","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.jaad.2016.12.021","article-title":"Suction blistering the lesional skin of vitiligo patients reveals useful biomarkers of disease activity","volume":"76","author":"Strassner","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1111\/exd.13952","article-title":"Expression analysis of PD-1 and Tim-3 immune checkpoint receptors in patients with vitiligo; positive association with disease activity","volume":"28","author":"Rahimi","year":"2019","journal-title":"Exp Dermatol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1111\/j.1398-9995.2007.01607.x","article-title":"Cytokine and chemokine expression in the skin from patients with maculopapular exanthema to drugs","volume":"63","author":"Fernandez","year":"2008","journal-title":"Allergy"},{"key":"B108","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.intimp.2008.11.013","article-title":"Detection of the Tim-3 ligand, galectin-9, inside the allograft during a rejection episode","volume":"9","author":"Naka","year":"2009","journal-title":"Int Immunopharmacol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.cellimm.2008.01.006","article-title":"The Tim-3 ligand galectin-9 negatively regulates CD8+ alloreactive T cell and prolongs survival of skin graft","volume":"250","author":"Wang","year":"2007","journal-title":"Cell Immunol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13075-018-1519-x","article-title":"A unique role for galectin-9 in angiogenesis and inflammatory arthritis","volume":"20","author":"O\u2019Brien","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"B111","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.imbio.2008.10.007","article-title":"Tim-3-galectin-9 pathway involves the suppression induced by CD4+ CD25+ regulatory T cells","volume":"214","author":"Wang","year":"2009","journal-title":"Immunobiology"},{"key":"B112","doi-asserted-by":"publisher","first-page":"3631","DOI":"10.4049\/jimmunol.170.7.3631","article-title":"Galectin-9 induces apoptosis through the calcium-calpain-caspase-1 pathway","volume":"170","author":"Kashio","year":"2003","journal-title":"J Immunol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1016\/j.gendis.2022.05.020","article-title":"A new emerging target in cancer immunotherapy: galectin-9 (LGALS9)","volume":"10","author":"Lv","year":"2023","journal-title":"Genes Dis"}],"container-title":["Frontiers in Allergy"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2025.1614277\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T05:39:05Z","timestamp":1752644345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2025.1614277\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,16]]},"references-count":113,"alternative-id":["10.3389\/falgy.2025.1614277"],"URL":"https:\/\/doi.org\/10.3389\/falgy.2025.1614277","relation":{},"ISSN":["2673-6101"],"issn-type":[{"value":"2673-6101","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,16]]},"article-number":"1614277"}}